|
|
 Dr. Lepor is an internationally-recognized authority in the treatment of prostate cancer. His major contributions in the area of prostate cancer include pioneering and improving the surgical technique for the nerve-sparing radical prostatectomy, establishing recombinant erythropoietin as a safe and effective blood management strategy for men undergoing radical prostatectomy, the development of an index to predict the return of continence following radical prostatectomy, and the evaluation of the Cavermap, a device intended to intraoperatively localize the nerves that are associated with erections.
Dr. Lepor is world-renowned for his research-driven approach to treating the prostate. In collaboration with his mentor at Johns Hopkins Hospital, Patrick Walsh, M.D., he helped pioneer surgical techniques for removing the prostate while preserving sexual function,which has made it much easier for men to accept prostate surgery. Since 1993, he has performed the operation more than 2,000 times,with results that are among the best in the nation. Dr. Lepor was appointed Chairman of Urology at NYU School of Medicine in 1993. At the time, he was the youngest chair of urology in the country. He has authored over 250 articles and book chapters and 10 textbooks related to the prostate.
Dr. Lepor is recognized as one of the 17 best urologists in America and one of the best urologists in New York City and the United States by Castle Connolly Medical, Ltd. Dr. Lepor was recently inducted into the Hopkins Society of Scholars, a distinction awarded yearly to twelve post doctoral graduates of John Hopkins University.
More about Dr. Lepor >>
Download Dr. Lepor's CV >>
|
